HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Martek Expands Access To DHA Food, Beverage Market With OmegaTech Buy

This article was originally published in The Tan Sheet

Executive Summary

Martek Biosciences is looking to gain greater access to the nascent DHA-fortified food and beverage market with the acquisition of Boulder, Colo.-based OmegaTech

You may also be interested in...



Investors Look For Solid Foundation Plus Potential In Nutritional Firms

Nutritional firms need to give off the right signals about their products' potential to generate investor interest in the increasingly competitive investment capital arena

More GRAS DHA for Martek

FDA affirms an alternative form of alga-derived docosahexaenoic acid for food applications, (different from the alga used in fortified infant formulas) as generally recognized as safe, Martek Biosciences announces March 3. Martek currently is in talks with food manufacturers to include the oil in cheese, yogurt and nutrition bars, and is hopeful their first DHA-containing food product will be out in 2004. The Columbia, Md.-based firm acquired the technology to make food-specific DHA via its 2003 purchase of OmegaTech (1"The Tan Sheet" April 1, 2003, p. 3)...

Martek Food/Beverage Sales Consolidated Under Senior VP Keller

Martek Biosciences Senior VP-Sales & Marketing Jerry Keller will assume responsibility for the firm's food and beverage business under a sales force restructuring announced July 29. Keller has overseen sales and marketing for infant formulas for five years

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS130190

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel